Surgical management of papillary thyroid carcinoma: an overview

被引:0
作者
Paolo Miccoli
Sohail Bakkar
机构
[1] University of Pisa,Division of Endocrine Surgery, Department of Surgical, Medical, Molecular Pathology and Critical Area
[2] The Hashemite University,Department of Surgery, Faculty of Medicine
来源
Updates in Surgery | 2017年 / 69卷
关键词
Papillary thyroid carcinoma; Surgical management; Thyroid lobectomy; Total thyroidectomy;
D O I
暂无
中图分类号
学科分类号
摘要
The surgical management of papillary thyroid carcinoma remains contentious and the optimal surgical strategy has not been yet established. The extent of thyroid resection has been the nub of this debate. Literature lacks prospective randomized controlled trials that could help put this debate to rest, and these have been labeled as being impractical. Consequently, large retrospective studies and expert opinion have constituted the basis of clinical practice guidelines. Recent American Thyroid Association and National Comprehensive Cancer Network guidelines consider a conservative approach in the form of a thyroid lobectomy sufficient for low-risk disease and that total thyroidectomy remains the standard of care in the presence of high-risk features. Nevertheless, many authorities still advocate more aggressive therapy for low-risk disease. The challenge in standardizing the surgical strategy to papillary thyroid carcinoma is mainly related to a major tumor characteristic: the high frequency of occult cancerous foci whether within the thyroid gland itself or within loco-regional lymph nodes as this tumor characteristic has been incriminated for a higher risk of recurrent disease and its adverse sequelae. The purpose of this article is to provide an overview of the surgical management of papillary thyroid carcinoma and the main arguments surrounding this hotly debated topic. All evidences for this review article were drawn from PubMed articles in English language mostly cross-referenced with international guideline statements.
引用
收藏
页码:145 / 150
页数:5
相关论文
共 380 条
[21]  
Nikiforov YE(2014)Total versus hemithyroidectomy for small unilateral papillary thyroid carcinoma Oncol Lett 7 849-853
[22]  
Pacini F(2013)Thyroid lobectomy for indeterminate FNA: not without consequences J Surg Res 184 189-192
[23]  
Randolph G(2015)Factors associated with postoperative hypothyroidism after lobectomy in papillary thyroid microcarcinoma patients Endocr Res 40 49-53
[24]  
Sawka A(2016)Frequency of high-risk characteristics requiring total thyroidectomy for 1–4 cm well-differentiated thyroid cancer Thyroid 26 820-824
[25]  
Schlumberger M(2016)The significance of unrecognized histological high-risk features on response to therapy in papillary thyroid carcinoma measuring 1–4 cm: implications for completion thyroidectomy following lobectomy Clin Endocrinol 85 150-151
[26]  
Schuff KG(2016)Apparently intrathyroid papillary thyroid carcinoma >1 and ≤4 cm: is the need for completion thyroidectomy common among patients submitted to lobectomy? Clin Endocrinol (Oxf) 161 127-133
[27]  
Sherman SI(2017)Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine Surgery 26 879-885
[28]  
Sosa JA(2002)Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients World J Surg 32 378-383
[29]  
Steward D(2007)Risk factors for permanent laryngeal nerve paralysis in patients with thyroid carcinoma Clin Otolaryngol 151 571-579
[30]  
Tuttle RM(2012)Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy Surgery 154 611-620